Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0955 Betaxolol
Selective beta-1 adrenergic receptor antagonist with antihypertensive and anti-glaucoma activities and devoid of intrinsic sympathomimetic activity
More description
DCC0954 Beta-nor-lapachone
Natural antibiofilm agent and adjuvant on the antifungal therapy related to resistant infections caused by C. glabrata
More description
DCC0953 Beta-erythroidine Hcl
Phytoestrogen, possessing typical curare-like action
More description
DCC0952 Beta-cit-fp
Potent ligand of the serotonin (5-HT) and dopamine (DA) transporters used in diagonisis of Parkinson's disease as SPECT imaging precursor
More description
DCC0951 Beta-blocker-15
Novel negative allosteric modulator of the ß2-adrenergic receptor (ß2AR), inhibiting cAMP production through the ß2AR, but not that mediated by other Gs-coupled receptors, also inhibiting ß-arrestin recruitment to the activated ß2AR
More description
DCC0950 Berotralstat Hydrochloride
Novel selective inhibitor of plasma kallikrein, blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE
More description
DCC0949 Berotralstat Analog
Novel inhibitor of plasma kallikrein
More description
DCC0948 Berberine-ornidazole
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove
More description
DCC0947 Berberine-benzothiazole-2-thiol
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove
More description
DCC0946 Bepridil
Long-acting calcium-blocking agent with significant anti-anginal activity
More description
DCC0945 Benzyl Vinyl Carbonate
Useful pharmaceutical building block
More description
DCC0944 Benzphetamine Hydrochloride
Anorectic, primarily promoting weight loss through reduced appetite
More description
DCC0943 Benzobicyclon
Inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), acting as a herbicide
More description
DCC0942 Benzavir-1
anti-HSV agent
More description
DCC0941 Benperidol Hydrochloride
Potent D2/D4 dopamine receptor antagonist, neuroleptic and antipsychotic
More description
DCC0940 Benorterone
Antiandrogen, being effective in the treatment of acne, seborrhea, and hirsutism in women
More description
DCC0939 Benmoxin
Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI)
More description
DCC0938 Benfluron Hydrochloride
Novel inhibitor of HIV-1 Rev function, also acting as a cytostatic agent with substantial antiretroviral activity
More description
DCC0937 Benc-511
Novel potent PI3K inhibitor, suppressing metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop, blocking AKT phosphorylation
More description
DCC0936 Benazepril
Inhibitor of angiotensin-converting enzyme (ACE); Prodrug of benazeprilat
More description
DCC0935 Benanserin Hydrochloride
Inhibitor of monoamine oxidase; Anti-serotonin agent
More description
DCC0934 Bemppox
Novel potent and specific inhibitor of dog gastric lipase (DGL)
More description
DCC0933 Behenyl Palmitate
Fatty Ester for Lipid Research
More description
DCC0932 beclomethasone 17-monopropionate
Active metabolite of beclomethasone dipropionate
More description
DCC0931 Bdoia383
Novel CBP/p300 Bromodomains inhibitor, binding BRD4 almost identical to SGC-CBP30
More description
DCC0930 Bdm41906
Novel specific bona fide EthR-inhibitor, boosting ETH 4 times in an intravenously infected TB mice model
More description
DCC0929 Bdm31827
Novel EthR inhibitor and ethionamide booster
More description
DCC0928 Bdm31369
Novel activator of ethionamide
More description
DCC0927 Bdm31343
Novel EthR inhibitor, boosting antituberculous activity of ethionamide
More description
DCC0926 Bdm14471
Potent and selective hydroxamate PfAM1 inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X